ArticleVaccine2025

PcrV in an intranasal adjuvanted tobacco mosaic virus conjugate vaccine mediates protection from Pseudomonas aeruginosa via an early Th1/Th17 skewed localized and systemic immune response.

Adiya S Katseff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.